The Hidden Link Between Obesity and Asthma: How Weight Affects Your Breathing
"Discover how obesity can trigger bronchial hyperresponsiveness and what you can do to improve your respiratory health."
Many people consider asthma an essential health problem, not everyone with asthma experiences the same symptoms. Bronchial hyperresponsiveness (BHR), a condition where the airways overreact to triggers, is a key factor. BHR can lead to airway inflammation and remodeling, making breathing difficult. Managing BHR is clinically important because it can increase the risk of developing asthma and chronic obstructive pulmonary disease (COPD).
Obesity has emerged as a significant risk factor for BHR, yet the specifics are still debated. Studies have shown conflicting results, with some finding a clear link between obesity and BHR, while others suggest the connection varies based on gender or other health conditions. Some research even indicates a negative correlation between body mass index (BMI) and BHR, adding to the confusion. These inconsistencies highlight the need for a deeper understanding of how obesity influences airway function and responsiveness.
One possible explanation involves small airway closure, a phenomenon where small airways in the lungs collapse, especially during exhalation. Obesity can reduce functional residual capacity (FRC), the amount of air remaining in the lungs after normal exhalation, making airway closure more likely. When airway closure occurs, it can increase airflow obstruction and BHR. Some studies suggest that airway closure might be a crucial link between obesity and BHR, potentially explaining why previous research has yielded conflicting results.
Asthma’s Current Burden
The CDC’s latest national and state tables, published August 27, 2026, describe the burden of asthma among children and adults using national and state surveillance systems. In 2022, 8.7% of U.S. adults age 18 and older and 6.2% of children younger than 18 currently had asthma. Asthma also accounted for 4.9 million annual office visits. California separately analyzes asthma data through infographics, an interactive dashboard, and downloadable datasets.
How Does Obesity Trigger Bronchial Hyperresponsiveness?
Researchers at the University of Melbourne investigated the relationship between obesity and BHR in middle-aged adults, utilizing data from the Tasmanian Longitudinal Health Study (TAHS). The study aimed to determine whether factors such as gender or asthma history influence this association and whether airway closure plays a causal role.
- Methacholine Challenge: Participants underwent a test to measure how their airways respond to methacholine, a substance that can trigger airway narrowing.
- Data Collection: Researchers gathered information on participants' BMI, asthma status, smoking habits, and other relevant health factors.
- Statistical Analysis: The team used statistical models to analyze the data and identify relationships between obesity, BHR, and other variables.
Weight and Airway Reactivity
A 2024 narrative review, Body Weight and Allergic Asthma, examined human studies from the previous 10 years on associations between asthma and obesity. A review of six large population-based studies, involving 700 to 11,000 participants, found that three reported a positive correlation between obesity and airway hyper-responsiveness. One study from China reported a U-shaped relationship, in which low BMI was also associated with airway hyper-responsiveness. Other cited research associates abdominal obesity with airway hyperresponsiveness, while obesity may facilitate small-airway closure through mechanical effects on airway diameter, particularly at low lung volumes.
Why Control Can Remain Difficult
Sources on severe asthma emphasize that some patients continue to have poor disease control despite advances in therapy and worldwide asthma guidelines. Severe or difficult-to-treat asthma may involve corticosteroid insensitivity and persistent lack of control despite corticosteroid treatment. Clinical management can also be complicated by steroid resistance or dependence, inhaler misuse, and the need to diagnose asthma accurately alongside coexisting conditions. The AAAAI notes that uncertainty about asthma management may contribute to questionable treatment decisions and poor self-monitoring.
Comparing Asthma Inhalers
A systematic review in mild-to-moderate asthma compared different inhalers by examining exacerbations, lung function, and asthma control. The review noted that the amount of evidence directly comparing inhalers in this population was limited. Separate inhaler overviews describe multiple treatment categories, ranging from rescue inhalers to biologics, and emphasize that inhalers do not all work in the same way.
Taking Control of Your Breathing
The study underscores the importance of maintaining a healthy weight to support respiratory function, particularly for those with asthma. By understanding the mechanisms that link obesity and BHR, we can develop targeted strategies to improve lung health and overall quality of life. If you’re concerned about your weight and breathing, consult with your healthcare provider to explore personalized solutions.
Expert Priorities in Asthma Care
The Scientific Committee of the Revolution in Asthma project reviewed expert findings across three areas: diagnosis, control, and treatment. The experts summarized clinicians’ main needs and questions and provided evidence-based responses and practical recommendations. Another expert opinion reported that stepwise, control-based pharmacological treatment using inhaled corticosteroids, long-acting beta agonists, and long-acting muscarinic antagonists generally provides good symptom control. Biologic therapies are often effective for T2-high severe asthma.
Personalized Asthma Care
The Future of Asthma Initiative brings together asthma clinicians and researchers to improve the lives of people with asthma, advocate for patients, identify improvement priorities, and develop a blueprint for future care. The Future of Asthma Care 2023 report identifies better patient engagement, greater personalization, wider access to data including artificial intelligence, scientific innovation, and longer-lasting medication as forces shaping new healthcare models. A separate market forecast projects the asthma disease market could reach USD 38.36 billion by 2035, with a 3.52% compound annual growth rate.
Evidence Beyond the Clinic
The UK Health and Safety Executive describes its asthma case studies as real incidents with real and often serious long-term consequences. A real-world evidence project in respiratory medicine examined treatment outcomes and patient satisfaction for a newly launched inhalation therapy used for asthma and chronic obstructive pulmonary disease. Another report states that asthma affects 26 million people in the United States and that severe cases drive substantial healthcare use and costs. It also reports benefits from Tezspire, or tezepelumab, in a Phase 4 real-world study.